Laura A. Lane

Corporate Officer/Principal at ELI LILLY AND COMPANY

Health Technology

Finance

Consumer Services

Profile

Laura A.
Lane was the founder of Virion Biotherapeutics Ltd.
which was founded in 2015, where she held the title of Chief Operating Officer & Director from 2015 to 2018.
Currently, she is a Vice President at Eli Lilly & Co. since 2022.
Previously, she worked as a Principal at Advent Venture Partners LLP from 2019 to 2022.
Ms. Lane received her undergraduate and doctorate degrees from the University of Cambridge.

Laura A. Lane active positions

Companies	Position	Start
ELI LILLY AND COMPANY	Corporate Officer/Principal	2022-07-31

All active positions of Laura A. Lane

Former positions of Laura A. Lane

Companies	Position	End
Advent Venture Partners LLP Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.	Private Equity Analyst	2021-09-30
Virion Biotherapeutics Ltd. Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom.	Founder	2018-06-29

See the detail of Laura A. Lane's experience

Training of Laura A. Lane

University of Cambridge

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Laura A. Lane's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ELI LILLY AND COMPANY	Health Technology

Private companies	2
Advent Venture Partners LLP Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.	Finance
Virion Biotherapeutics Ltd. Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom.	Health Technology